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Abstract 
Herpesvirus infections are common and can cause serious and life-threatening conditions in 
transplanted individuals. In this thesis, consisting of 4 papers (I-IV), we investigated primary 
infection and reactivation of Cytomegalovirus (CMV), Human Herpesvirus type 6 (HHV-6), 
Varicella Zoster Virus (VZV) and Epstein-Barr Virus (EBV) in transplant patients. The overall 
aim was to expand our knowledge on the incidence, prophylaxis, management and long-term 
effects of herpesvirus infections after transplantation. The studies were all retrospective. Results 
from serum and whole blood analyses by quantitative polymerase chain reaction (PCR) for 
CMV and HHV-6 in a cohort of 97 adult allo-SCT patients (papers I and II) and CMV and EBV 
in 58 renal transplanted children (paper IV) were compiled. VZV antibodies were analyzed 
using ELISA assays and immunofluorescence from blood samples of 85 renal transplanted 
children (paper III).  
In paper I, patients with CMV DNAemia had improved survival compared to CMV negative 
patients. There was an increased risk of CMV DNAemia with a seronegative donor to a 
seropositive recipient. CMV disease with debut more than 110 days after transplantation was 
related to steroid treatment for Graft versus Host Disease (GVHD).The morbidity associated 
with HHV-6 DNAemia following allo-SCT was in most cases mild. The overall one-year 
survival among the patients with HHV-6 DNAemia was not significantly different from the 
HHV-6 negative patients (paper II). At renal transplantation, protective VZV antibody-levels 
were less frequent and of lower magnitude in varicella-vaccinated children than in those with 
previous varicella. Vaccinated patients then lost their seropositivity to a greater extent than 
previously infected individuals. Herpes zoster was only seen in previously infected children 
(paper III). Long-lasting chronic high EBV load carriage (CHL) was seen in 24% of the renal 
transplant patients despite reduced immunosuppression. CHL carriage mainly developed in 
younger children. None developed post-transplant lymphoproliferative disorder (PTLD) during 
the median follow up of almost 8 years (paper IV). To conclude, the incidence of herpesvirus 
DNAemia is high after transplantation. VZV-vaccination and antiviral prophylaxis against 
CMV and VZV as well as pre-emptive CMV treatment and surveillance of EBV DNA are life-
saving and reduces the long-term effects of herpesvirus infections. 
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